Fresenius Kabi Oncology Ltd. | FKONCO | NSE - Pharmaceuticals


Performance  |  Valuation  |  Growth  |  Insiders  |  Summary

Financial Summary Report of Fresenius Kabi Oncology Ltd.



FKONCO
Fresenius Kabi Oncology Ltd.

Rs. 132.50
02-Jan-2014

5 Yr Performance

1 Yr Performance

Valuation




Analysis




Quarterly Revenue, Net Income and Adjusted Share Price




Peer Comparison


Aurobindo Pharma Ltd.

Biocon Ltd.

Cipla Ltd.

RPG Life Sciences Limited

Divis Laboratories Ltd.

Dr. Reddy's Laboratories Ltd.

Glaxosmithkline Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd.

Ipca Laboratories Ltd.

Lupin Ltd.